Recent Finacing
Recent Raise
Cardioxyl Pharmaceuticals is a clinical-stage company in Chapel Hill developing HNO (nitroxyl) donor therapeutics, including lead candidate CXL-1020, for acute and chronic heart failure.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors